ArticleJournal of experimental & clinical cancer research : CR2026

Targeting PSMD14 enhances immunotherapy efficacy by promoting PD-L1 degradation and reshaping the tumor microenvironment in breast cancer.

Shichao Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.